US Stocks
/
Exelixis, Inc. Share Price

Exelixis, Inc. Share Price

NASDAQ: EXEL | Large Cap
$59.86
+$0.82 (1.39%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Exelixis, Inc. Stock Performance

Open
$59.18
Prev. Close
$59.04
Circuit Range
N/A
Day Range
$59.17 - $60.78
Year Range
$33.76 - $61.14
Volume
1,30,235
Average Traded
$60.23

Exelixis, Inc. Share Price Today

As of 11 October 2026, Exelixis, Inc.'s share price is $59.86. The stock opened at $59.18, compared to its previous close of $59.04. During today's trading session, Exelixis, Inc.'s share price traded between $59.17 and $60.78, with an average price of $59.98. Over the past 52 weeks, the stock has recorded a high of $61.14 and a low of $33.76. In terms of performance, Exelixis, Inc.'s share price has risen by 34.61% over the last six months and is up 54.88% on a year-on-year basis.

Exelixis, Inc. Share Price Chart

$59.17$60.78
L
Show Current Price
H

Exelixis, Inc. Stock Fundamentals & Key Indicators

Market Cap
$16.26B
PE Ratio (TTM)
17.23
Dividend Yield
0.00%
EPS (TTM)
$3.47
Revenue (TTM)
$2.32T
Return On Equity (TTM)
46.68%
Profit Margin
33.73%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
9.54%

Exelixis, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsOct 2025Jan 2026Apr 2026Jul 2026
Revenue$597.76$598.66$610.81$628.69
Net Profit$193.58$244.53$210.47$212.05
Net Profit Margin32.38%40.85%34.46%33.73%
Income ChangeN/A26.32%-13.93%0.75%

Exelixis, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1611.06$1830.21$2168.70$2320.13
Net Profit$182.28$207.77$521.27$782.57
Net Profit Margin11.31%11.35%24.04%33.73%
Income ChangeN/A13.98%150.89%50.13%

About Exelixis, Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

Exelixis, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$58.29
$59.83
+2.38%
Sep 2026
$55.09
$58.44
+5.76%
Aug 2026
$52.81
$55.26
+4.17%
Jul 2026
$54.34
$53.05
-2.48%
Jun 2026
$50.68
$54.40
+7.73%
May 2026
$44.06
$50.49
+13.54%
Apr 2026
$42.91
$44.47
+3.68%
Mar 2026
$41.95
$42.89
-2.62%
Feb 2026
$41.85
$44.05
+6.52%
Jan 2026
$43.52
$41.35
-5.62%
Dec 2025
$43.62
$43.81
-0.80%
Nov 2025
$37.77
$44.16
+14.27%

EXEL Share Price FAQs

What is Exelixis, Inc. share price today?

chevron-up
Exelixis, Inc. share price today is $59.86 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Exelixis, Inc. stock?

chevron-up
The 52 week high of Exelixis, Inc. stock is $61.14, while the 52 week low is $33.76 as of 10 Oct '26.

What is EXEL's market capitalisation today?

chevron-up
EXEL market capitalisation is $16.26B as of October 11, 2026, at 2:06 am IST.

What is EXEL's net income for the last quarter?

chevron-up
EXEL's net income for the last quarter is 212.05B USD.

What is the 5 year returns of EXEL?

chevron-up
The 5 year returns of EXEL is 178.29% as on 10 Oct '26.

What is the high & low stock price of EXEL today?

chevron-up
EXEL stock price hit a high of $60.78 and low of $59.17 as of 10 Oct '26.

Can I buy EXEL shares in India?

chevron-up
Yes. You can buy EXEL in India by opening an international trading account.